Viral Hepatitis Elimination Program in Ukraine (National program)

Viral Hepatitis Elimination Program in Ukraine (National program)

Virus targets
Hepatitis B
Hepatitis C
Type
Technical assistance
Testing and treatment implementation
Setting
National
Other targets
HIV
Phase
Active
Health outcomes
Incidence
Mortality
WHO region
European Region
Country
Ukraine
Key interventions
Blood safety
Community mobilization
Hepatitis B Vaccination
Injection safety and infection control
Persons who inject drugs: HCV cure as prevention
Persons who inject drugs: Medication assisted therapy
Persons who inject drugs: Syringe service program(s)
Prevention mother-child transmission
Strategic data analysis
Screening and diagnosis
Treatment (direct or referral)
Target population
Adolescents (10 - 19 years of age)
Adults (> 19 years of age)
Blood transfusion recipients
Children (> one year < 10 years of age)
Incarcerated populations (current and former)
Infants (less than one year of age)
Men who have sex with men
Newborn (born in last 30 days)
Occupations with possible exposure
Persons who inject drugs
Pregnant women
Performance target
Blood safety
Care cascade: HBV diagnosis
Care cascade: HBV testing
Care cascade: HBV treatment
Care cascade: HCV diagnosis
Care cascade: HCV testing
Care cascade: HCV treatment
Harm reduction (access to safe injection equipment for persons who inject drugs)
HBV prevention of mother to child transmission
Hepatitis B vaccination coverage
Injection safety
If you would like to have a program page for your program, please create an account and submit program information here

Health outcomes additional info

Reduce incidence by 90%, reduce mortality by 65%; improve HBV vaccination by 90%, prevent 90% HBV transmission from mother to child, achieve 100% donor blood checked, 90% coverage of safe injections, 300 syringes per year for harm reduction, diagnose 90% of people living with HBV/HCV, 80% of people with chronic HBV and HCV on treatment.

Performance target additional info

To reduce incidence by 30%, mortality by 10%; achieve HBV vaccination of 90%, prevent 50% HBV transmission from mother to child, 95% of donor blood is checked, 50% coverage of safe injections, 200 syringes per year per PWID in harm reduction services, 30% of people living with HBV/HCV diagnosed, HBV treatment for 5 million people and 3 million people for HCV treatment.

Last updated